Fu YX - Search Results

1

Is CD47 an innate immune checkpoint for tumor evasion?

Liu X, Kwon H, Li Z, Fu YX. Liu X, et al. Among authors: fu yx. J Hematol Oncol. 2017 Jan 11;10(1):12. doi: 10.1186/s13045-016-0381-z. J Hematol Oncol. 2017. PMID: 28077173 Free PMC article. Review.

2

The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses.

Wang Y, Subudhi SK, Anders RA, Lo J, Sun Y, Blink S, Wang Y, Wang J, Liu X, Mink K, Degrandi D, Pfeffer K, Fu YX. Wang Y, et al. Among authors: fu yx. J Clin Invest. 2005 Mar;115(3):711-7. doi: 10.1172/JCI22982. J Clin Invest. 2005. PMID: 15696194 Free PMC article.

3

NF-kappaB2 is required for the establishment of central tolerance through an Aire-dependent pathway.

Zhu M, Chin RK, Christiansen PA, Lo JC, Liu X, Ware C, Siebenlist U, Fu YX. Zhu M, et al. Among authors: fu yx. J Clin Invest. 2006 Nov;116(11):2964-71. doi: 10.1172/JCI28326. Epub 2006 Oct 12. J Clin Invest. 2006. PMID: 17039258 Free PMC article.

4

Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastases.

Yu P, Lee Y, Wang Y, Liu X, Auh S, Gajewski TF, Schreiber H, You Z, Kaynor C, Wang X, Fu YX. Yu P, et al. Among authors: fu yx. J Immunol. 2007 Aug 1;179(3):1960-8. doi: 10.4049/jimmunol.179.3.1960. J Immunol. 2007. PMID: 17641063 Free PMC article.

5

Lymphotoxin beta receptor is required for the migration and selection of autoreactive T cells in thymic medulla.

Zhu M, Chin RK, Tumanov AV, Liu X, Fu YX. Zhu M, et al. Among authors: fu yx. J Immunol. 2007 Dec 15;179(12):8069-75. doi: 10.4049/jimmunol.179.12.8069. J Immunol. 2007. PMID: 18056347

6

The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity.

Park S, Jiang Z, Mortenson ED, Deng L, Radkevich-Brown O, Yang X, Sattar H, Wang Y, Brown NK, Greene M, Liu Y, Tang J, Wang S, Fu YX. Park S, et al. Among authors: fu yx. Cancer Cell. 2010 Aug 9;18(2):160-70. doi: 10.1016/j.ccr.2010.06.014. Cancer Cell. 2010. PMID: 20708157 Free PMC article.

7

Cetuximab-mediated tumor regression depends on innate and adaptive immune responses.

Yang X, Zhang X, Mortenson ED, Radkevich-Brown O, Wang Y, Fu YX. Yang X, et al. Among authors: fu yx. Mol Ther. 2013 Jan;21(1):91-100. doi: 10.1038/mt.2012.184. Epub 2012 Sep 18. Mol Ther. 2013. PMID: 22990672 Free PMC article.

8

Targeting the tumor microenvironment with interferon-β bridges innate and adaptive immune responses.

Yang X, Zhang X, Fu ML, Weichselbaum RR, Gajewski TF, Guo Y, Fu YX. Yang X, et al. Among authors: fu ml, fu yx. Cancer Cell. 2014 Jan 13;25(1):37-48. doi: 10.1016/j.ccr.2013.12.004. Cancer Cell. 2014. PMID: 24434209 Free PMC article.

9

CD47 blockade triggers T cell-mediated destruction of immunogenic tumors.

Liu X, Pu Y, Cron K, Deng L, Kline J, Frazier WA, Xu H, Peng H, Fu YX, Xu MM. Liu X, et al. Among authors: fu yx. Nat Med. 2015 Oct;21(10):1209-15. doi: 10.1038/nm.3931. Epub 2015 Aug 31. Nat Med. 2015. PMID: 26322579 Free PMC article.

10

CTLA-4 Limits Anti-CD20-Mediated Tumor Regression.

Ren Z, Guo J, Liao J, Luan Y, Liu Z, Sun Z, Liu X, Liang Y, Peng H, Fu YX. Ren Z, et al. Among authors: fu yx. Clin Cancer Res. 2017 Jan 1;23(1):193-203. doi: 10.1158/1078-0432.CCR-16-0040. Epub 2016 Jun 27. Clin Cancer Res. 2017. PMID: 27354469 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

594 results

Search Page

Filters